Pyridine

Pyridine

SCHEMBL1807180

CCCCCOCCCCC.c1ccncc1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.45
THRB P10828 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
MAPT P10636 1/20 0.45
TSHR P16473 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
NAPRT Q6XQN6 1/20 0.41
LMNA P02545 3/20 0.40
CYP3A4 P08684 3/20 0.38
CYP2D6 P10635 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LTA4H P09960 1/20 0.38
CES2 O00748 1/20 0.38
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP19A1 P11511 1/20 0.37
NPC1 O15118 2/20 0.37
CYP1A2 P05177 1/20 0.37
NFKB1 P19838 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL28839411 0.93 TSHR (0.46) MEN1THRBHTTKMT2AMAPT
Pyridine SCHEMBL11030451 0.86 LMNA (0.39) MEN1THRBHTTKMT2AMAPT
Pyridine SCHEMBL7125704 0.86 LMNA (0.39) MEN1THRBHTTKMT2AMAPT
Pyridine SCHEMBL11440854 0.86 LMNA (0.39) MEN1THRBHTTKMT2AMAPT
Benzene SCHEMBL27778100 0.85 HTT (0.56) MEN1THRBHTTKMT2AMAPT
Hexane SCHEMBL5964926 0.85 TSHR (0.56) MEN1THRBHTTKMT2AMAPT
Hexane SCHEMBL11222760 0.85 TSHR (0.56) MEN1THRBHTTKMT2AMAPT
Pyridazine SCHEMBL27817273 0.84 HTT (0.46) MEN1THRBHTTKMT2AMAPT
Hexane SCHEMBL11381748 0.84 TDP1 (0.43) MEN1THRBKMT2AMAPTTSHR
Butoxyethanol SCHEMBL3861200 0.84 TSHR (0.65) MEN1THRBHTTKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951972-B2 Human adam-10 inhibitors EXELIXIS, INC. (US) 2011-05-31 US disclosed
EP-1461313-B1 HUMAN ADAM-10 INHIBITORS EXELIXIS INC (US) 2009-08-05 EP disclosed
US-20050227973-A1 Human adam-10 inhibitors EXELIXIS, INC. 2005-10-13 US disclosed
EP-1461313-A1 HUMAN ADAM-10 INHIBITORS Exelixis, Inc. (US) 2004-09-29 EP disclosed
WO-2003051825-A1 HUMAN ADAM-10 INHIBITORS EXELIXIS, INC. (US) 2003-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227973-A1 Human adam-10 inhibitors ADAM10, ADAM12, ADAM9 MEN1 4431/4885THRB 4153/4885HTT 3782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.